🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
7.93
+1.18 (17.48%)
At close: Nov 19, 2026, 4:00 PM EST
8.48
+0.55 (6.94%)
After-hours: Nov 19, 2026, 7:46 PM EST

Moleculin Biotech Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
9.119.128.7910.0211.548.39
Research & Development
20.4315.8917.7319.4918.9714.42
Operating Expenses
29.5825.126.6429.6330.6422.97
Operating Income
-29.58-25.1-26.64-29.63-30.64-22.97
Interest & Investment Income
0.030.110.551.370.240.31
Other Non Operating Income (Expenses)
18.13-8.560.04-1.511.386.77
EBT Excluding Unusual Items
-11.42-33.56-26.05-29.77-29.03-15.89
Pretax Income
-11.42-33.56-26.05-29.77-29.03-15.89
Net Income
-11.42-33.56-26.05-29.77-29.03-15.89
Preferred Dividends & Other Adjustments
-2.760.1----
Net Income to Common
-8.66-33.66-26.05-29.77-29.03-15.89
Net Income Growth
------
Shares Outstanding (Basic)
00----
Shares Outstanding (Diluted)
00----
Shares Change
916.15%-----
EPS (Basic)
-25.34-568.38----
EPS (Diluted)
-42.13-568.38----
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-27.1-22.74-23.88-23.72-27.71-18.97
Free Cash Flow Per Share
-79.33-383.86----
EBITDA
-29.55-25.01-26.52-29.5-30.51-22.8
D&A For EBITDA
0.030.090.130.130.130.16
EBIT
-29.58-25.1-26.64-29.63-30.64-22.97
SEC Filings: 10-K · 10-Q